Most cited papers from Southeast Renal Research Institute
What are the most cited papers from Southeast Renal Research Institute?
The most cited paper from Southeast Renal Research Institute is "Risk Prediction of Contrast-Induced Nephropathy" (Peter Andrew McCullough, Andy Adam, Christoph R. Becker et al., 2006), with 461 citations. Next come "Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy" (436) and "Pathophysiology of Contrast-Induced Nephropathy" (395).
Showing 24 of 24 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Risk Prediction of Contrast-Induced Nephropathy Peter Andrew McCullough, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology | 24 Feb 2006 | 461 |
| 2 | Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy Peter Andrew McCullough, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology | 11 Feb 2006 | 436 |
| 3 | Pathophysiology of Contrast-Induced Nephropathy James Alan Tumlin, Fulvio Stacul, Andy Adam et al. · The American Journal of Cardiology | 20 Feb 2006 | 395 |
| 4 | Strategies to Reduce the Risk of Contrast-Induced Nephropathy Fulvio Stacul, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology | 21 Mar 2006 | 256 |
| 5 | Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis Julia Breyer Lewis, Mohammed Sika, Mark J. Koury et al. · Journal of the American Society of Nephrology | 24 Jul 2014 | 192 |
| 6 | Contrast Medium Use Charles J. Davidson, Fulvio Stacul, Peter Andrew McCullough et al. · The American Journal of Cardiology | 3 Mar 2006 | 170 |
| 7 | Economic burden of contrast-induced nephropathy: implications for prevention strategies Sujha Subramanian, James Alan Tumlin, Bela Bapat et al. · Journal of Medical Economics | 2007 | 148 |
| 8 | Baseline Renal Function Screening Norbert Hendrik Lameire, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology | 21 Feb 2006 | 121 |
| 9 | Proposal for a Functional Classification System of Heart Failure in Patients With End-Stage Renal Disease Lakhmir S. Chawla, Charles A. Herzog, Maria Rosa Costanzo et al. · Journal of the American College of Cardiology | 12 Feb 2014 | 93 |
| 10 | Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography Roxana Mehran, Michela Faggioni, Jaya Chandrasekhar et al. · JACC: Cardiovascular Interventions | Aug 2018 | 47 |
| 11 | Overview Peter Andrew McCullough, Fulvio Stacul, Charles J. Davidson et al. · The American Journal of Cardiology | 14 Feb 2006 | 43 |
| 12 | High-Risk Situations and Procedures Christoph R. Becker, Charles J. Davidson, Norbert Hendrik Lameire et al. · The American Journal of Cardiology | 21 Feb 2006 | 40 |
| 13 | Soluble urokinase receptor and focal segmental glomerulosclerosis Jochen Reiser, Changli Wei, James Alan Tumlin · Current Opinion in Nephrology & Hypertension | 8 May 2012 | 36 |
| 14 | A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Improvement of Hemodialysis Catheter Function James Alan Tumlin, Jesse M. Goldman, David M. Spiegel et al. · Clinical Journal of the American Society of Nephrology | 4 Feb 2010 | 32 |
| 15 | Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis Moustafa Sherief Moustafa, George R. Aronoff, Chandra B. Chandran et al. · Clinical and Vaccine Immunology | 26 Jul 2012 | 30 |
| 16 | Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG‐4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo‐Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients Robert Provenzano, James Alan Tumlin, Raja I. Zabaneh et al. · The Journal of Clinical Pharmacology | 30 Jun 2020 | 29 |
| 17 | Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1 James Alan Tumlin, Claude M. Galphin, Brad H. Rovin · Journal of Diabetes Research | 2013 | 25 |
| 18 | Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial Javier A Neyra et al. · The Lancet Respiratory Medicine | 23 Mar 2026 | 20 |
| 19 | Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy James Alan Tumlin · Current Opinion in Critical Care | 7 Nov 2009 | 20 |
| 20 | Bayesian methods: a potential path forward for sepsis trials GEORGE A. TOMLINSON, Ali H. Al-Khafaji, Steven A. Conrad et al. · Critical Care | 8 Nov 2023 | 19 |
| 21 | Organ Failure, Endotoxin Activity, and Mortality in Septic Shock Luca Molinari, Mark Tidswell, Ali H. Al-Khafaji et al. · Critical Care Explorations | 28 Aug 2025 | 3 |
| 22 | 254 Pharmacokinetics of Oral FG-4592 to Treat Anemia in Hemodialysis (HD) Patients (PTS) Robert Provenzano, James Alan Tumlin, Raja I. Zabaneh et al. · American Journal of Kidney Diseases | Apr 2011 | 2 |
| 23 | 3: COMBINATION OF ENDOTOXIN ACTIVITY AND SOFA DEFINES SEVERITY IN SEPTIC SHOCK Mark Tidswell, Ali H. Al-Khafaji, Danielle L Davison et al. · Critical Care Medicine | 2025 | 1 |
| 24 | 227 James Alan Tumlin, Claude M. Galphin, Mandeep Singh Grewal · American Journal of Kidney Diseases | Apr 2007 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.